Miao Shou Doctor

EqualOcean and Skepsos Sign Strategic Cooperation Memorandum of Understanding

On May 20, 2025, Beijing EO Technology Co.,Ltd and the Greater Paris Health Industry Park (Skepsos) officially signed a Memorandum of Understanding on Strategic Cooperation in Beijing.

Trump Launches "Section 232 Investigations" into Semiconductors and Pharmaceuticals

Capital Frenzy: AI Healthcare's Inflection Point

Is AI healthcare now approaching its own “DeepSeek Moment” as it rides a new wave of momentum?

China's First Modified New Drug of Docetaxel Successfully Went to the US

Under the Fractured Global Supply Chain, How Is United Imaging Shaping a Global "Chain"

Under the Fractured Global Supply Chain, How Is United Imaging Shaping a Global "Chain" Connection?

How Can MedTech Leverage Technological Innovation and Strategic Precision to Go-Global

How Can MedTech Companies Leverage Technological Innovation and Strategic Precision to Expand Globally? | Highlights from GGF2024

CelcomDigi Berhad and AmBank Sign MOU to Drive Digital Healthcare Transformation

CelcomDigi Berhad today announced the signing of a three-year Memorandum of Understanding (MoU) with AmBank (M) Berhad and AmBank Islamic Berhad, with the aim of empowering healthcare providers in Malaysia through digital healthcare solutions.

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Yilite Technology Completes A+ Round Financing of CNY 100 Million

Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.

CRO Enterprise ICE Bioscience Completes B++ Round of Financing

ICE Bioscience is dedicated to new drug targets and drug discovery.

Big Vision Medical Secures Financing of USD 30 Million in the Ophthalmology Field

Big Vision Medical Accelerates Innovation and Global Expansion in Ophthalmology.

AI Medical Company Subtle Medical Secures Nearly Ten Mn USD in Series B+ Financing Round

Subtle Medical is expected to exceed a billion CNY in global revenue in 2024.

VINNO, Tian Yuan: Chinese Speed and Innovation Lead the Medical Device Industry

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Robo CT Partner Wang Xiaoqi: Winning the International Stage with Manufacturing Excellence

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Haier Biomedical 'Smart Blood City Network' Lands in Brazil

Brazil, as the largest country and economy in South America, faces numerous challenges brought about by an aging population. With the country's economy continuing to grow, healthcare issues are receiving increasing attention, and the demand for medical services is rising year by year.

D3 Bio Completes A+ Round Financing, Accelerates Development of Product Pipeline

EqualOcean has learned that on April 8, 2024, D3 Bio(德昇济医药), a biotechnology company focused on the development and commercialization of innovative cancer and immune precision therapies, announced the successful completion of its A+ round financing led by Medicxi, a prominent European life sciences investment firm. The financing amounted to USD 62 million, with existing investor, Matrix Partners(经纬创投), also participating.

Insilico Medicine submitted a listing application to the Hong Kong Stock Exchange

On March 27, Insilico Medicine, an AI drug research and development company, once again submitted its listing application to the Hong Kong Stock Exchange.